BIOIX
Price
$65.47
Change
+$1.97 (+3.10%)
Updated
Jun 12 closing price
Net Assets
2.06B
GFACX
Price
$71.50
Change
+$0.19 (+0.27%)
Updated
Jun 12 closing price
Net Assets
360.63B
Interact to see
Advertisement

BIOIX vs GFACX

Header iconBIOIX vs GFACX Comparison
Open Charts BIOIX vs GFACXBanner chart's image
BIOIX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
BIOIX vs. GFACX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOIX is a Hold and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 361B vs. BIOIX (2.06B). BIOIX (0.00) and GFACX (0.00) have matching dividends . BIOIX was incepted earlier than GFACX: BIOIX (17 years) vs GFACX (25 years). GFACX (1.35) is less costly to investors than BIOIX (1.05). GFACX is a more actively managed with annual turnover of: 32.00 vs. BIOIX (30.00). GFACX has a lower initial minimum investment than BIOIX: GFACX (250) vs BIOIX (1000000). BIOIX annual gain was more profitable for investors over the last year : 24.07 vs. GFACX (5.82). BIOIX return over 5 years is better than : 43.99 vs. GFACX (8.45).
BIOIXGFACXBIOIX / GFACX
Total Expense Ratio1.051.3578%
Annual Report Gross Expense Ratio1.051.3578%
Fund Existence17 years25 years-
Gain YTD12.6276.241202%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.06B361B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year24.075.82414%
Returns for 3 years92.5636.16256%
Returns for 5 years43.998.45521%
Returns for 10 years302.6484.56358%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSXPX72.390.87
+1.22%
Goldman Sachs Small Cp Val Insghts P
RNWEX105.540.88
+0.84%
American Funds New World R4
TRBIX30.960.25
+0.81%
Nuveen Small Cap Blend Idx Retire
GSVTX17.680.13
+0.74%
Goldman Sachs Large Cap Value Inv
BRTNX81.010.44
+0.55%
Bretton Fund